ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 39 filers reported holding ATYR PHARMA INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,000 | 0.0% | 10,504 | +36.6% | 0.00% | – |
| Q1 2019 | $4,000 | 0.0% | 7,687 | 0.0% | 0.00% | – |
| Q4 2018 | $4,000 | -33.3% | 7,687 | 0.0% | 0.00% | – |
| Q3 2018 | $6,000 | -83.3% | 7,687 | -80.4% | 0.00% | – |
| Q2 2018 | $36,000 | -67.6% | 39,287 | -6.1% | 0.00% | – |
| Q1 2018 | $111,000 | -24.0% | 41,831 | 0.0% | 0.00% | – |
| Q4 2017 | $146,000 | -36.8% | 41,831 | -8.5% | 0.00% | – |
| Q3 2017 | $231,000 | +44.4% | 45,732 | -3.0% | 0.00% | – |
| Q2 2017 | $160,000 | -4.2% | 47,132 | -1.2% | 0.00% | – |
| Q1 2017 | $167,000 | +50.5% | 47,708 | -7.9% | 0.00% | – |
| Q4 2016 | $111,000 | -32.3% | 51,782 | +0.2% | 0.00% | – |
| Q3 2016 | $164,000 | +1.2% | 51,693 | -11.4% | 0.00% | – |
| Q2 2016 | $162,000 | +315.4% | 58,339 | +1379.9% | 0.00% | – |
| Q4 2015 | $39,000 | – | 3,942 | +19610.0% | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 20 | -88.0% | 0.00% | – |
| Q2 2015 | $3,000 | – | 167 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,827,992 | $3,930,000 | 4.66% |
| EcoR1 Capital, LLC | 976,986 | $2,101,000 | 0.67% |
| TANG CAPITAL MANAGEMENT LLC | 279,425 | $601,000 | 0.32% |
| Rock Springs Capital Management LP | 475,000 | $1,021,000 | 0.07% |
| Quotient Investors, LLC | 22,200 | $48,000 | 0.03% |
| Alyeska Investment Group, L.P. | 1,072,108 | $2,305,000 | 0.02% |
| TIVERTON ASSET MANAGEMENT LLC | 95,318 | $205,000 | 0.01% |
| RIVERHEAD CAPITAL MANAGEMENT LLC | 79,677 | $171,000 | 0.01% |
| Acrospire Investment Management LLC | 12,683 | $27,000 | 0.01% |
| Glen Harbor Capital Management LLC | 179,724 | $386,000 | 0.01% |